In-person dinner, networking & presentation
The National Club, 303 Bay St.
August 19, 2026
Join Jason Markwell and Kavita Ramamoorthy as they discuss the recent Supreme Court of Canada decision on methods of medical treatment. What are the key takeaways from this decision? Is the analysis of what constitutes an unpatentable method of medical treatment more clear now? Could the decision have consequences for other types of patents? This presentation will offer a lively discussion of where litigants stand post PMS v. Janssen.
Jason Markwell, of Markwell Clarizio LLP, is a patent litigator and drug regulatory lawyer with more than 25 years of experience. He has acted as counsel in precedent-setting cases before the Supreme Court of Canada, the Federal Court of Appeal, the Federal Court, the Ontario Superior Court of Justice, and the Patented Medicine Prices Review Board. He has been recognized by Chambers & Partners, IAM Patent 1000, Best Lawyers Canada, Lexpert, Benchmark Litigation, Managing Intellectual Property, and LMG Life Sciences.
Kavita Ramamoorthy, of Fineberg Ramamoorthy LLP, has practiced pharmaceutical patent law since 2003. She has extensive experience in patent litigation, proceedings under the PMNOC Regulations, patent actions, judicial reviews, and regulatory matters, and has appeared frequently before the Federal Court and Federal Court of Appeal. Kavita is a registered Canadian Patent Agent, holds a Ph.D. in Toxicology, and has been recognized by Chambers & Partners, Best Lawyers in Canada, Managing IP, and Who's Who Legal.
Doors and wine at 6; dinner and presentation about 7.
